Visual Performance of Dailies Total1 Multifocal and Acuvue Oasys Max 1-Day Multifocal in Presbyopic Lens Wearers (GIRAFFE)

December 4, 2024 updated by: University of Waterloo
The purpose of this study is to measure the logMAR visual acuity when presbyopic soft lens wearers are fit with Dailies Total1 Multifocal and ACUVUE OASYS MAX 1-DAY Multifocal.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • Centre for Ocular Research & Education (CORE)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Are at least 42 years of age and has full legal capacity to volunteer;
  2. Have signed an information consent letter;
  3. Are willing and able to follow instructions and maintain the appointment schedule;
  4. Habitually wears soft contact lenses for the past 3 months (minimum);
  5. Are presbyopic and require a reading addition of at least +0.75D and no more than +1.75D;
  6. Can be refracted and achieve monocular spectacle distance vision of at least 20/25 Snellen (or +0.10logMAR) visual acuity;
  7. Have contact lens power requirements that fall within the available study lens parameters (distance sphere: +6D to -9D; near addition as per each lens design);
  8. Can be fit with the initial fitting guidelines provided by the lens manufacturer and use either Low or Medium Add (same add in both eyes).

Exclusion Criteria:

  1. Are a current habitual wearer of Dailies Total1 Multifocal or ACUVUE OASYS MAX 1-DAY Multifocal;
  2. Has refractive astigmatism higher than -0.75DC in either eye;
  3. Are participating in any concurrent clinical or research study involving intervention or invasive ocular tests;
  4. Have any known active ocular disease and/or infection;
  5. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  6. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  7. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  8. Have undergone refractive error surgery;
  9. Are a member of the Centre for Ocular Research & Education (CORE) directly involved in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dailies Total1 Multifocal, ACUVUE OASYS MAX 1-Day Multifocal
Fit participant with Dailies Total1 Multifocal first, and with ACUVUE OASYS MAX 1-Day Multifocal second.
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.
Other Names:
  • Dailies Total1 Multifocal
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia
Other Names:
  • ACUVUE OASYS MAX 1-DAY Multifocal
Experimental: ACUVUE OASYS MAX 1-Day Multifocal, Dailies Total1 Multifocal
Fit participant with ACUVUE OASYS MAX 1-Day Multifocal first, and with Dailies Total1 Multifocal second.
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.
Other Names:
  • Dailies Total1 Multifocal
Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia
Other Names:
  • ACUVUE OASYS MAX 1-DAY Multifocal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High contrast visual acuity (logMAR) at 6m
Time Frame: Day 1
High contrast visual acuity (logMAR) for the dominant eye under photopic illumination at 6m
Day 1
High contrast visual acuity (logMAR) at 40cm
Time Frame: Day 1
High contrast visual acuity (logMAR) for the dominant eye under photopic illumination at 40cm
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Lyndon Jones, PhD, FCOptom, Centre for Ocular Research & Education (CORE)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 25, 2024

Primary Completion (Actual)

November 21, 2024

Study Completion (Actual)

November 21, 2024

Study Registration Dates

First Submitted

April 12, 2024

First Submitted That Met QC Criteria

April 12, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Estimated)

December 6, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 46238

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on Deleficon A (multifocal)

Subscribe